Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Peijia Medical Raises $100 Million for Medical Device Development

publication date: Nov 6, 2019

Peijia Medical, a Suzhou interventional medical device maker, raised $100 million in a series C funding that was led by Matrix Partners China, which also led Peijia's A round. Founded in 2012, Peijia claims to have developed China's first cardiovascular drug-eluting stent and intracranial embolization coil. Other investors in the C round included Lily Asia Ventures, SDIC Fund Management Company, Grand Flight Investment and Chengtong Fund. Peijia claimed the C round is one of the largest venture rounds on record for a China device maker. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here